Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 637
Filter
Add more filters

Publication year range
1.
Clin Exp Immunol ; 196(2): 139-154, 2019 05.
Article in English | MEDLINE | ID: mdl-30663040

ABSTRACT

Current therapies for inflammatory bowel diseases (IBD) are aimed at controlling the exacerbated response in the gut, but no treatment is fully effective for many refractory patients. Mesenchymal stromal cells (MSC) are multi-potent cells with regulatory immunosuppressive activity that may control inflammatory diseases. In this study, we investigated the short- and especially the long-term protective effects of MSC on experimental colitis. We show that MSC elicited protection to acute intestinal inflammation with gain of weight, improvement in the clinical disease score and expressive reduction in the mortality rate of treated mice. MSC changed the population of neutrophils, eosinophils and augmented the frequency of CD4 T lymphocytes in the gut-draining lymph nodes, together with reduced accumulation of these cells in the colon intraepithelial compartment. Interestingly, there were increased levels of programmed death 1 (PD-1) and glucocorticoid-induced tumour necrosis factor receptor family-related receptor (GITR) in the spleen regulatory T cells of mice that received MSC treatment, which also presented a reversal in the pattern of immune response in the gut, with diminished inflammatory, T helper type 1 (Th1) and Th17 profile, in contrast to augmented Th2 responses. Most strikingly, this balanced response elicited by a single administration of MSC during the acute colitis persisted long-term, with restored goblet cells, eosinophils and maintenance of elevated gut interleukin (IL)-4, besides increased CD4+ CD25+ PD-1+ cells in the spleen and reduced Th17 response in mesenteric lymph nodes (MLN) of treated mice on day 60. Taken together, our findings provided a significant contribution to translational immunology by pointing human adipose tissue-derived MSC as a novel therapeutic approach with long-term beneficial regulatory effects in experimental colitis.


Subject(s)
Adipose Tissue/immunology , Colitis/immunology , Inflammation/immunology , Mesenchymal Stem Cells/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , Colon/immunology , Cytokines/immunology , Disease Models, Animal , Female , Glucocorticoid-Induced TNFR-Related Protein/immunology , Humans , Inflammatory Bowel Diseases/immunology , Intestinal Mucosa/immunology , Lymph Nodes/immunology , Mice , Mice, Inbred BALB C , Programmed Cell Death 1 Receptor/immunology , Spleen/immunology , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Regulatory/immunology
2.
Cryo Letters ; 38(1): 1-6, 2017.
Article in English | MEDLINE | ID: mdl-28376134

ABSTRACT

BACKGROUND: In the vitrification of embryos, dimethyl sulfoxide (DMSO) is one of the most effective cryoprotectant agents (CPAs), but cytotoxic effects of DMSO on embryos are well known. Carboxylated poly-L-lysine (CPLL) has been identified as an effective cryoprotectant of cultured cell lines and mammalian oocytes. OBJECTIVE: To evaluate the efficacy and safety of CPLL as a CPA for developmental stage embryos. MATERIALS AND METHODS: Mouse 8-cell embryos and blastocysts were vitrified with ethylene glycol (EG), DMSO/EG, or CPLL/EG and the developmental potency assessed in vitro. RESULTS: In 8-cell embryos, there were no differences between the levels of survival and developmental progress into the blastocyst stage in each solution. At the blastocyst stage, the proportion of dead cells was significantly higher in the EG compared with other solutions. In contrast, there were no differences between the DMSO/EG and CPLL/EG. CONCLUSION: These results indicate that CPLL can be used as a replacement for DMSO in the vitrification of mouse embryos.


Subject(s)
Blastocyst/drug effects , Cryopreservation/methods , Cryoprotective Agents/pharmacology , Embryonic Development/drug effects , Polylysine/pharmacology , Animals , Dimethyl Sulfoxide/pharmacology , Ethylene Glycol/pharmacology , Female , Mice , Oocytes/drug effects , Vitrification
3.
Colorectal Dis ; 14(2): 194-9, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21689277

ABSTRACT

AIM: The aim of the present study was to conduct a psychometric validation of the Japanese version of the FIQL (JFIQL). METHOD: A retrospective analysis of data from the JFIQL was conducted. Wexner scores and Faecal Incontinence Severity Index (FISI) scores were collected prospectively in patients with faecal incontinence who visited our centre between 2008 and 2009. For convergent validity, the JFIQL scores were compared with stages on the Wexner scale for lifestyle alteration. To evaluate reliability, Cronbach's alpha was calculated for internal consistency, whereas a test-retest study was performed to evaluate reproducibility. In assessing responsiveness, JFIQL scores before and after treatments were compared in patients whose FISI scores decreased by ≥ 50%. RESULTS: Convergent validity and internal consistency were determined in 70 patients (49 women; median age 68.5 years). The JFIQL scores were significantly associated with lifestyle alteration stages on the Wexner scale, demonstrating convergent validity in all four domains and the generic score. Cronbach's alpha was > 0.7 for generic scores and all domains except Embarrassment. The intraclass correlations for the 27 patients available for the test-retest study were > 0.7 for generic scores and all domains except Embarrassment. The median JFIQL score improved significantly after treatment in the 23 patients whose FISI scores decreased ≥ 50%, indicating good responsiveness in all four domains and the generic score. CONCLUSION: The JFIQL has been validated and is now ready for use in evaluating the symptom-specific quality of life in Japanese patients with faecal incontinence.


Subject(s)
Fecal Incontinence/psychology , Quality of Life/psychology , Surveys and Questionnaires , Aged , Aged, 80 and over , Analysis of Variance , Female , Humans , Japan , Language , Male , Middle Aged , Psychometrics , Reproducibility of Results , Retrospective Studies
4.
Int J Clin Pharmacol Ther ; 49(7): 415-21, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21726491

ABSTRACT

OBJECTIVE: Although the concentration of α1-acid glycoprotein (AGP) in serum increases under some conditions, the behavior of the individual genetic variants is not well understood. Therefore, we studied the relative changes in AGP variants pre- and postoperatively in patients with cancer and patients with chronic inflammatory disease states, as well as the distribution of AGP phenotypes in a Japanese population. METHODS: Serum samples were taken before and after surgery from 25 female patients with early breast cancer. Serum samples were also obtained from 134 patients with rheumatoid arthritis (RA) and 33 with systemic lupus erythematosus (SLE), and from 103 healthy subjects. The relative concentrations of the individual genetic variants in the serum samples were determined by isoelectric focusing after desialylation with neuraminidase. RESULTS: The postoperative AGP concentrations in patients with early breast cancer were 2-fold higher than before surgery. The relative concentrations of the F1 and S variants were significantly increased, whereas that of the A variant was not changed significantly. The relative concentrations of all the AGP variants in patients with RA and SLE were significantly higher than those in healthy subjects. The distribution of the AGP phenotypes did not differ significantly among the groups examined in this study. CONCLUSIONS: The F1/S variants of AGP, but not the A variant, were significantly increased after early breast cancer surgery, but all the variants were increased in patients with chronic inflammatory states such as RA and SLE. The distribution of the AGP phenotypes did not differ significantly among the disease groups studied.


Subject(s)
Breast Neoplasms/metabolism , Inflammation/metabolism , Orosomucoid/metabolism , Adolescent , Adult , Arthritis, Rheumatoid/metabolism , Breast Neoplasms/surgery , Chronic Disease , Female , Genetic Variation , Humans , Isoelectric Focusing , Japan/epidemiology , Lupus Erythematosus, Systemic/metabolism , Middle Aged , Orosomucoid/chemistry , Orosomucoid/genetics , Phenotype , Surgical Procedures, Operative , Young Adult
5.
J Exp Med ; 189(11): 1777-82, 1999 Jun 07.
Article in English | MEDLINE | ID: mdl-10359581

ABSTRACT

Toll-like receptor 4 (TLR4) is a mammalian homologue of Drosophila Toll, a leucine-rich repeat molecule that can trigger innate responses against pathogens. The TLR4 gene has recently been shown to be mutated in C3H/HeJ and C57BL/10ScCr mice, both of which are low responders to lipopolysaccharide (LPS). TLR4 may be a long-sought receptor for LPS. However, transfection of TLR4 does not confer LPS responsiveness on a recipient cell line, suggesting a requirement for an additional molecule. Here, we report that a novel molecule, MD-2, is requisite for LPS signaling of TLR4. MD-2 is physically associated with TLR4 on the cell surface and confers responsiveness to LPS. MD-2 is thus a link between TLR4 and LPS signaling. Identification of this new receptor complex has potential implications for understanding host defense, as well as pathophysiologic, mechanisms.


Subject(s)
Antigens, Surface/immunology , Drosophila Proteins , Lipopolysaccharides/pharmacology , Membrane Glycoproteins/immunology , Receptors, Cell Surface/immunology , Animals , Antigens, Surface/genetics , Base Sequence , Cell Line , DNA, Complementary/genetics , Humans , Lymphocyte Antigen 96 , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Molecular Sequence Data , NF-kappa B/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Cell Surface/genetics , Sequence Homology, Amino Acid , Signal Transduction , Toll-Like Receptor 4 , Toll-Like Receptors , Transfection
6.
J Exp Med ; 171(1): 321-6, 1990 Jan 01.
Article in English | MEDLINE | ID: mdl-1688610

ABSTRACT

The function of thymic B cells in several standard in vitro assays was investigated. Thymic B cells, 75% of which were CD5+, showed a poor responsiveness to the mitogens LPS or anti-mu plus IL-4. Both proliferation and antibody formation were much lower in thymic than splenic B cell cultures. However, CD5- B cells purified using a cell sorter responded well to B cell stimulants, whereas purified CD5+ thymic B cells did not, indicating that CD5+ thymic B cells were unresponsive to B cell growth factor or LPS. Thymic B cells could be activated polyclonally by direct interaction with alloreactive T blasts, as manifested by DNA synthesis and antibody formation. These findings indicate that CD5+ thymic B cells may not be stimulated via sIg and IL-4, but require instead direct interaction with T blasts.


Subject(s)
Antigens, Differentiation/analysis , B-Lymphocytes/immunology , Histocompatibility Antigens Class II/immunology , Interleukin-4/pharmacology , Lymphocyte Activation , T-Lymphocytes/immunology , Thymus Gland/immunology , Animals , Antibodies, Monoclonal , B-Lymphocytes/drug effects , CD5 Antigens , Cells, Cultured , Genes, MHC Class II , Immunoglobulin M/immunology , Kinetics , Mice , Mice, Inbred C3H , Mice, Inbred Strains
7.
J Exp Med ; 192(1): 23-9, 2000 Jul 03.
Article in English | MEDLINE | ID: mdl-10880523

ABSTRACT

The susceptibility to infections induced by Gram-negative bacteria is largely determined by innate immune responses to bacteria cell wall lipopolysaccharide (LPS). The stimulation of B cells by LPS enhances their antigen-presenting capacity and is accompanied by B cell proliferation and secretion of large quantities of LPS-neutralizing antibodies. Similar to macrophages and neutrophils, the LPS-induced activation of B cells is dependent on Toll-like receptor (TLR)4. Here, we demonstrate that the responses of B cells to LPS are also regulated by another TLR protein, RP105, which is predominantly expressed on mature B cells in mice and humans. The analysis of mice homozygous for the null mutation in the RP105 gene revealed impaired proliferative and humoral immune responses of RP105-deficient B cells to LPS. Using originally LPS-unresponsive Ba/F3 cells expressing exogenous TLR4 and RP105, we demonstrate the functional cooperation between TLR4 and RP105 in LPS-induced nuclear factor kappaB activation. These data suggest the existence of the TLR4-RP105 signaling module in the LPS-induced B cell activation.


Subject(s)
Antigens, CD , B-Lymphocytes/immunology , Lipopolysaccharides/pharmacology , Membrane Proteins/physiology , Signal Transduction/immunology , Animals , Antigens, Surface/physiology , B-Lymphocytes/drug effects , Cell Line , Cells, Cultured , Crosses, Genetic , Exons , Lymph Nodes/immunology , Lymphocyte Activation/drug effects , Membrane Proteins/deficiency , Membrane Proteins/genetics , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Knockout , NF-kappa B/metabolism , Repetitive Sequences, Amino Acid , Signal Transduction/drug effects , Spleen/immunology , T-Lymphocytes/immunology
8.
J Exp Med ; 168(2): 811-6, 1988 Aug 01.
Article in English | MEDLINE | ID: mdl-3261779

ABSTRACT

A small number of B cells are found in the thymus of normal mice. A population of B lymphocytes could be enriched to greater than 90% purity by isolating a low-density fraction on Percoll density gradients and then depleting T cells with a mixture of anti-Thy-1, CD4, and CD8 mAbs and complement. Enrichment was monitored by surface Ig staining and by functional studies (responsiveness to LPS, and to anti-mu plus IL-4). When the phenotype of these B cells was studied by flow cytometry, 60-80% had the phenotype Ly-1+ (CD5), Ia+, B220low (CD45R), and Mac-1+ (CD 11b). In contrast, splenic B cells lacked CD5 and CD11b and expressed higher levels of B220 and Ia antigens. These results indicate that most thymic B cells have the phenotype of the Ly-1 B cell subset, which was identified previously as a trace subpopulation in some peripheral tissues and is thought to play a role in autoantibody formation.


Subject(s)
B-Lymphocytes/immunology , Thymus Gland/immunology , Animals , Antibodies, Monoclonal , B-Lymphocytes/classification , Cells, Cultured , Female , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Organ Specificity , Reference Values , Spleen/immunology
9.
Curr Top Microbiol Immunol ; 328: 89-121, 2009.
Article in English | MEDLINE | ID: mdl-19216436

ABSTRACT

Acanthamoeba polyphaga Mimivirus, the first representative and prototype member of the Mimiviridae, is the latest addition to the menagerie of lesser-known big DNA viruses. Due to the size of its particle--a fiber-covered icosahedral protein capsid with a diameter of 0.7 microm--Mimivirus was initially mistaken for an intracellular parasitic bacteria. Its 1.2-Mb genome sequence was then found to encode more than 900 proteins, many of them associated with functions never before encountered in a virus, such as four aminoacyl-tRNA synthetases. The finding of Mimivirus-encoded central components of the protein translation apparatus thought to be the signature of cellular organisms revived the debate about the origin of DNA viruses and their possible role in the emergence of the eukaryotic cell. Despite the many features making it unique in the viral world, Mimivirus is nevertheless phylogenetically close to other large DNA viruses, such as phycodnaviruses and iridoviruses, and most likely share a common ancestry with all nucleocytoplasmic large DNA viruses. Postgenomic studies have now started in various laboratories, slowly shedding some light on the physiology of the largest and most complex virus isolated to date. This chapter summarizes our present knowledge on Mimivirus.


Subject(s)
Acanthamoeba/virology , DNA Viruses/physiology , Animals
10.
Endoscopy ; 42(7): 541-5, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20593331

ABSTRACT

BACKGROUND AND STUDY AIMS: Video capsule endoscopy has been established in diagnosis of small-bowel disease and has been evaluated for esophageal pathology and recently for colorectal diagnostics. Gastric capsule endoscopy has not hitherto been feasible due to the stomach's large surface area and volume. We present the first application of a magnetically navigated capsule in the human stomach. PATIENTS AND METHODS: 29 volunteers and 24 patients (men 42, women 11; mean age 47.5 years) were included in a feasibility study. Low-level magnetic fields were used to maneuver the double-sensor video capsule within the human stomach with an air-water interface provided by ingestion of 1300 ml water within 1 hour before examination. Visualization of all parts of the stomach was attempted; time for visualization was recorded, and a subjective assessment of completeness of visualization was documented. RESULTS: There was technical failure in one individual; thus technical success rate was 98 %. In the 52 remaining cases, examiners assessed that the antrum, body, fundus, and cardia were fully visualized in 98 %, 96 %, 73 % and 75 %, respectively. Mean duration of examinations was 30 minutes (range 8 - 50), with a longer time (mean 37 minutes) for volunteers for study reasons. In total, 30 findings were identified: 14 were detected by both gastroscopy and capsule, 10 lesions were identified by guided capsule examination only, 6 by gastroscopy only. No significant capsule-related adverse events occurred. CONCLUSION: Magnetically navigated video capsule endoscopy appears to be feasible and sufficiently accurate for gastric examination. It may permit endoscopic examinations that are more patient-friendly and without sedation. Comparative studies are under way.


Subject(s)
Capsule Endoscopy/methods , Stomach Diseases/diagnosis , Adult , Aged , Feasibility Studies , Female , Humans , Magnetics , Male , Middle Aged , Stomach , Young Adult
11.
Science ; 290(5490): 347-50, 2000 Oct 13.
Article in English | MEDLINE | ID: mdl-11030655

ABSTRACT

Rickettsia conorii, the aetiological agent of Mediterranean spotted fever, is an intracellular bacterium transmitted by ticks. Preliminary analyses of the nearly complete genome sequence of R. conorii have revealed 44 occurrences of a previously undescribed palindromic repeat (150 base pairs long) throughout the genome. Unexpectedly, this repeat was found inserted in-frame within 19 different R. conorii open reading frames likely to encode functional proteins. We found the same repeat in proteins of other Rickettsia species. The finding of a mobile element inserted in many unrelated genes suggests the potential role of selfish DNA in the creation of new protein sequences.


Subject(s)
Bacterial Proteins/genetics , DNA, Bacterial/genetics , Interspersed Repetitive Sequences , Open Reading Frames/genetics , RNA, Messenger/genetics , Rickettsia conorii/genetics , Rickettsia/genetics , Bacterial Proteins/chemistry , Base Sequence , Conserved Sequence , Evolution, Molecular , Genome, Bacterial , Molecular Sequence Data , Mutagenesis, Insertional , Nucleic Acid Conformation , Protein Biosynthesis , Protein Conformation , Protein Structure, Secondary , RNA, Bacterial/chemistry , RNA, Bacterial/genetics , RNA, Bacterial/metabolism , RNA, Messenger/chemistry , RNA, Messenger/metabolism
12.
Science ; 293(5537): 2093-8, 2001 Sep 14.
Article in English | MEDLINE | ID: mdl-11557893

ABSTRACT

Rickettsia conorii is an obligate intracellular bacterium that causes Mediterranean spotted fever in humans. We determined the 1,268,755-nucleotide complete genome sequence of R. conorii, containing 1374 open reading frames. This genome exhibits 804 of the 834 genes of the previously determined R. prowazekii genome plus 552 supplementary open reading frames and a 10-fold increase in the number of repetitive elements. Despite these differences, the two genomes exhibit a nearly perfect colinearity that allowed the clear identification of different stages of gene alterations with gene remnants and 37 genes split in 105 fragments, of which 59 are transcribed. A 38-kilobase sequence inversion was dated shortly after the divergence of the genus.


Subject(s)
Evolution, Molecular , Genome, Bacterial , Rickettsia conorii/genetics , Rickettsia prowazekii/genetics , Adaptation, Physiological , Chlamydia/genetics , Computational Biology , DNA, Bacterial/genetics , DNA, Intergenic , Gene Dosage , Gene Silencing , Gene Transfer, Horizontal , Genes, Bacterial , Open Reading Frames , Phylogeny , Polymerase Chain Reaction , Repetitive Sequences, Nucleic Acid , Rickettsia/genetics , Rickettsia conorii/physiology , Rickettsia prowazekii/physiology , Sequence Analysis, DNA , Transcription, Genetic
13.
Epidemiol Infect ; 137(12): 1691-8, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19426573

ABSTRACT

The aim was to estimate the incidence of Mycobacterium tuberculosis (Mtb) infection in health-care workers (HCWs) in Japan. We repeated cross-sectional surveys of HCWs with QuantiFERON-TB Gold (QFT-G) in 2003, 2005 and 2007 at a hospital with tuberculosis (TB) wards, and 311 HCWs who underwent QFT-G testing two or three times were included in the study. Five HCWs (1.8%) converted from negative to positive. Incidence of new TB infection was estimated to be 0.6/100 person-years by the CDC's definition. Thirteen positive persons (41%) reverted from positive to negative. Multivariable logistic regression analysis identified a significant association between QFT-G conversion and working in TB wards. The IFN-gamma levels of all but two subjects with reverting or converting QFT-G results were close to the test's cut-off. The incidence of Mtb infection in HCWs at our hospital was higher than that estimated for the general population in Japan. Criteria for defining QFT-G conversion and reversion need further investigation considering the high proportion of reversion, as the incidence of infection would have changed if we had applied other definitions.


Subject(s)
Health Personnel , Interferon-gamma/blood , Tuberculosis/epidemiology , Adult , Aged , Cross-Sectional Studies , Female , Hospitals , Humans , Incidence , Japan/epidemiology , Male , Middle Aged , Young Adult
14.
Clin Nephrol ; 71(6): 660-8, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19473635

ABSTRACT

BACKGROUND: Falecalcitriol is a novel vitamin D analog, which has a greater potential to suppress parathyroid hormone (PTH) and a longer half-life. There are few studies to compare clinical effects of oral falecalcitriol treatment with those of intravenous calcitriol treatment. METHODS: Twenty-one patients with moderate to severe SHPT were included in a random 2 x 2 crossover trial with the two vitamin D analogs (12 weeks for each treatment). The primary endpoint measure was a decrease in serum intact PTH (iPTH) level, and the secondary outcome measures included changes in serum calcium (Ca), phosphate (P), and metabolic bone marker levels. RESULTS: Both treatments decreased iPTH and whole PTH (wPTH) levels by similar degrees (iPTH, -200.1 +/- 107.0 with falecalcitriol vs. -200.8 +/- 114.9 pg/ml with calcitriol, p = 0.9895; wPTH, -137.1 +/- 73.1 with falecalcitriol vs. -120.4 +/- 81.1 pg/ml with calcitriol, p = 0.5603). Serum Ca, P, and Ca x P product levels at the end of each treatment were comparable and the frequencies of hypercalcemia and hyperphosphatemia were also similar during each treatment period. Although intravenous calcitriol treatment significantly changed intact osteocalcin and cross-linked N-telopeptide of type I collagen after 12 weeks, oral falecalcitriol treatment did not change any bone metabolic marker level. CONCLUSION: The present study showed that oral falecalcitriol treatment is effective for PTH suppression, and Ca and P metabolism in hemodialysis patients with moderate to severe SHPT, as well as intravenous calcitriol administration.


Subject(s)
Bone Density Conservation Agents/administration & dosage , Calcitriol/analogs & derivatives , Calcitriol/administration & dosage , Hyperparathyroidism, Secondary/drug therapy , Administration, Oral , Alkaline Phosphatase/blood , Biomarkers/blood , Bone and Bones/drug effects , Bone and Bones/metabolism , Calcium/blood , Collagen Type I/blood , Collagen Type I/drug effects , Cross-Over Studies , Female , Humans , Hyperparathyroidism, Secondary/etiology , Injections, Intravenous , Kidney Failure, Chronic/therapy , Male , Middle Aged , Osteocalcin/blood , Osteocalcin/drug effects , Parathyroid Hormone/blood , Peptides/blood , Peptides/drug effects , Phosphorus/blood , Renal Dialysis/adverse effects , Treatment Outcome
15.
J Dent Res ; 98(5): 534-540, 2019 05.
Article in English | MEDLINE | ID: mdl-30848974

ABSTRACT

Although they are known to share pathophysiological processes, the relationship between periodontitis and chronic obstructive pulmonary disease (COPD) is not fully understood. The aim of the present study was to test the hypothesis that periodontitis is associated with a greater risk of development of COPD, when smoking is taken into account. The analysis in a 5-y follow-up population-based cohort study was based on 900 community-dwelling Japanese adults (age: 68.8 ± 6.3 [mean ± SD], 46.0% male) without COPD aged 60 or older with at least 1 tooth. Participants were classified into 3 categories according to baseline periodontitis severity (no/mild, moderate, and severe). COPD was spirometrically determined by a fixed ratio of <0.7 for forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) and by FEV1/FVC below the lower limit of normal. Poisson regression was used to calculate the relative risk (RR) of developing COPD according to the severity of periodontitis. The population attributable fraction (PAF) was also calculated. During follow-up, 22 (2.4%) subjects developed COPD. Compared with no/mild periodontitis subjects, a significantly increased risk of COPD occurred among severe periodontitis subjects (RR = 3.55; 95% confidence interval [CI], 1.18 to 10.67), but no significant differences were observed between the no/mild and moderate categories (RR = 1.48; 95% CI, 0.56 to 3.90). After adjustment for potential confounders, including smoking intensity, the relationship between severe periodontitis and risk of COPD remained significant (RR = 3.51; 95% CI, 1.15 to 10.74). Likewise, there was a positive association of periodontitis severity with risk of COPD ( P for trend = 0.043). The PAF for COPD due to periodontitis was 22.6%. These data highlight the potential importance of periodontitis as a risk factor for COPD.


Subject(s)
Periodontitis , Pulmonary Disease, Chronic Obstructive , Aged , Cohort Studies , Female , Forced Expiratory Volume , Humans , Male , Middle Aged , Risk Factors , Spirometry
16.
Acta Neurochir Suppl ; 103: 109-12, 2008.
Article in English | MEDLINE | ID: mdl-18496954

ABSTRACT

In this study we report our surgical results of CAS and CEA for carotid stenosis and suggest an appropriate treatment strategy for patients with high risks such as bilateral carotid stenosis or medical risk factors. From January 2001 to December 2005 we surgically treated 182 patients with carotid stenosis. Seventy-nine lesions were treated by CEA and 145 by CAS, respectively. Although CEA was considered the first choice for severe carotid stenosis, CAS was chosen for treatment when CEA was considered a higher risk for patients. Stenosis of carotid arteries was relieved in all cases after CEA or CAS. Surgical mortality of CEA was 1.1% (1/94). Surgical mortality of CAS was 0.7% (1/145). Carotid stenotic lesions can be treated with comparably low morbidity and mortality rates using CEA or/and CAS considering each characteristic of carotid stenosis of patients even with medically high risk or bilateral carotid stenosis.


Subject(s)
Angioplasty, Balloon/methods , Carotid Stenosis/surgery , Endarterectomy, Carotid/methods , Stents , Aged , Aged, 80 and over , Blood Vessel Prosthesis , Carotid Stenosis/epidemiology , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Assessment , Risk Factors , Treatment Outcome
17.
Oncogene ; 25(17): 2520-30, 2006 Apr 20.
Article in English | MEDLINE | ID: mdl-16474852

ABSTRACT

Recently, DNA methylation and reduced expression of the suppressor of the cytokine signaling-3 (SOCS3) gene in human hepatocellular carcinoma (HCC) patients have been reported. However, the roles of SOCS3 in HCC development in vivo have not been clarified. Using RT-PCR analysis and Western blotting, we confirmed that SOCS3 expression was reduced in HCC patients. However, reduced expression of SOCS3 occurred not only in HCC but also in nontumor regions, and this reduction was stronger as the fibrosis grade increased. Furthermore, SOCS3 levels were inversely correlated with signal transducers and activators of transcription-3 (STAT3) activation as well as transforming growth factor (TGF)-beta1 levels in the non-HCC region. To define the molecular consequences of SOCS3 silencing/STAT3 hyperactivation and liver fibrosis, we examined liver-specific SOCS3-deficient mice. We demonstrated that SOCS3 deletion in the liver resulted in hyperactivation of STAT3 and promoted ConA- and chemical-induced liver fibrosis. The expression of TGF-beta1, a mediator of fibrosis, was enhanced by SOCS3 gene deletion, but suppressed by the overexpression of a dominant-negative STAT3 or SOCS3 both in vivo and in vitro. These data suggest that TGF-beta1 is a target gene of STAT3 and could be one of the mechanisms for enhanced fibrosis in SOCS3-deficient mice. Thus, our present study provides a novel role of SOCS3 and STAT3 in HCC development: in addition to the previously characterized oncogenic potentials, STAT3 enhances hepatic fibrosis through the upregulation of TGF-beta1 expression, and SOCS3 prevents this process.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Liver Cirrhosis/metabolism , Liver Neoplasms/metabolism , Liver/metabolism , STAT3 Transcription Factor/metabolism , Suppressor of Cytokine Signaling Proteins/physiology , Transforming Growth Factor beta/biosynthesis , Animals , Blotting, Western , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Gene Expression Regulation , Gene Silencing , Genes, Dominant , Humans , Integrases , Liver/injuries , Liver Cirrhosis/pathology , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Mice , Mice, Knockout , Reverse Transcriptase Polymerase Chain Reaction , STAT3 Transcription Factor/genetics , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/genetics , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta1
18.
Oncogene ; 25(45): 6056-66, 2006 Oct 05.
Article in English | MEDLINE | ID: mdl-16652141

ABSTRACT

Aberrant activation of the Ras/Raf-1/extracellular-regulated kinase (ERK) pathway has been shown to be involved in the progression of human hepatocellular carcinoma (HCC). However, the mechanism of dysregulation of ERK activation is poorly understood. Recently, we identified Sprouty-related protein with Ena/vasodilator-stimulated phosphoprotein homology-1 domain (Spred) as a physiological inhibitor of the Ras/Raf-1/ERK pathway. In this study, we found that the expression levels of Spred-1 and -2 in human HCC tissue were frequently decreased, comparing with those in adjacent non-tumorous tissue. Moreover, Spred expression levels in HCC tissue were inversely correlated with the incidence of tumor invasion and metastasis. Forced expression of Spred-1 inhibited HCC cell proliferation in vitro and in vivo, which was associated with reduced ERK activation. Spred-1 overexpression also reduced the secretion of matrix metalloproteinase-9 (MMP-9) and MMP-2, which play important roles in tumor invasion and metastasis. In addition, Spred-1 inhibited growth factor-mediated HCC cell motility. These data indicate that the reduction of Spred expression in HCC is one of the causes of the acquisition of malignant features. Thus, Spred could be not only a novel prognostic factor but also a new therapeutic target for human HCC.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Intracellular Signaling Peptides and Proteins/physiology , Liver Neoplasms/metabolism , Repressor Proteins/physiology , Signal Transduction/physiology , ras Proteins/metabolism , Adaptor Proteins, Signal Transducing , Adolescent , Adult , Aged , Base Sequence , Blotting, Western , Carcinoma, Hepatocellular/enzymology , Carcinoma, Hepatocellular/pathology , DNA Primers , Female , Humans , Immunohistochemistry , Liver Neoplasms/enzymology , Liver Neoplasms/pathology , Male , Membrane Proteins , Middle Aged , Phenotype , Reverse Transcriptase Polymerase Chain Reaction
19.
Physiol Res ; 56(1): 57-65, 2007.
Article in English | MEDLINE | ID: mdl-16497096

ABSTRACT

Inactive forearm muscle oxygenation has been reported to begin decreasing from the respiratory compensation point (RCP) during ramp leg cycling. From the RCP, hyperventilation occurs with a decrease in arterial CO2 pressure (PaCO2). The aim of this study was to determine which of these two factors, hyperventilation or decrease in PaCO2, is related to a decrease in inactive biceps brachii muscle oxygenation during leg cycling. Each subject (n = 7) performed a 6-min two-step leg cycling. The exercise intensity in the first step (3 min) was halfway between the ventilatory threshold and RCP (170+/-21 watts), while that in the second step (3 min) was halfway between the RCP and peak oxygen uptake (240+/-28 watts). The amount of hyperventilation and PaCO2 were calculated from gas parameters. The average cross correlation function in seven subjects between inactive muscle oxygenation and amount of hyperventilation showed a negative peak at the time shift of zero (r = -0.72, p<0.001), while that between inactive muscle oxygenation and calculated PaCO2 showed no peak near the time shift of zero. Thus, we concluded that decrease in oxygenation in inactive arm muscle is closely coupled with increase in the amount of hyperventilation.


Subject(s)
Bicycling/physiology , Hyperventilation/physiopathology , Leg/physiology , Muscle, Skeletal/metabolism , Oxygen Consumption/physiology , Adult , Anaerobic Threshold/physiology , Carbon Dioxide/blood , Exercise/physiology , Exercise Test , Heart Rate/physiology , Hemoglobins/metabolism , Humans , Lactic Acid/blood , Male , Myoglobin/metabolism , Oxyhemoglobins/metabolism , Spectroscopy, Near-Infrared
20.
Physiol Res ; 56(2): 169-174, 2007.
Article in English | MEDLINE | ID: mdl-16555947

ABSTRACT

The purpose of the present study was to examine whether the level of oxygen uptake (V(.)(O2) at the onset of decrement-load exercise (DLE) is lower than that at the onset of constant-load exercise (CLE), since power output, which is the target of V(.)(O2) response, is decreased in DLE. CLE and DLE were performed under the conditions of moderate and heavy exercise intensities. Before and after these main exercises, previous exercise and post exercise were performed at 20 watts. DEL was started at the same power output as that for CLE and power output was decreased at a rate of 15 watts per min. V(.)(O2) in moderate CLE increased at a fast rate and showed a steady state, while V(.)(O2) in moderate DLE increased and decreased linearly. V(.)(O2) at the increasing phase in DLE was at the same level as that in moderate CLE. V(.)(O2) immediately after moderate DLE was higher than that in the previous exercise by 98+/-77.5 ml/min. V(.)(O2) in heavy CLE increased rapidly at first and then slowly increased, while V(.)(O2) in heavy DLE increased rapidly, showing a temporal convexity change, and decreased linearly. V(.)(O2) at the increasing phase of heavy DLE was the same level as that in heavy CLE. V(.)(O2) immediately after heavy DLE was significantly higher than that in the previous exercise by 156+/-131.8 ml/min. Thus, despite the different modes of exercise, V(.)(O2) at the increasing phase in DLE was at the same level as that in CLE due to the effect of the oxygen debt expressed by the higher level of V(.)(O2) at the end of DLE than that in the previous exercise.


Subject(s)
Exercise/physiology , Muscle, Skeletal/metabolism , Oxygen Consumption , Oxygen/metabolism , Adult , Anaerobic Threshold , Humans , Kinetics , Male
SELECTION OF CITATIONS
SEARCH DETAIL